Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
This prostate-specific gene encodes a cytoplasmic protein, as well as a polytopic membrane protein which may serve as a target in prostate cancer diagnosis and immunotherapy. Zusätzlich bieten wir Ihnen Anoctamin 7 Antikörper (34) und viele weitere Produktgruppen zu diesem Protein an.
Showing 4 out of 5 products:
ANO7 genotypes correlate with expression and biochemical relapse, suggesting that ANO7 is a potential PrCa susceptibility gene and that its elevated expression correlates with disease severity and outcome.
high level of NGEP expression could be associated with good prognosis in prostate cancer
NGEP protein is widely expressed in low-grade to high-grade prostate adenocarcinomas as well as benign prostate tissues, and the intensity of expression is inversely proportional to the level of malignancy.
expressed only in prostate and prostate camcer is a promising target for the antibody-based therapies of prostate cancer
Complete coding sequence of TMEM16G cDNA was determined by assembling 25 exons of TMEM16G gene
description of the novel prostate-restricted molecule D-TMPP widely expressed in prostate cancer tissues
NGEP is a glycoprotein with predicted glycosylation sites at N809 and N824. When these residues were converted to glutamine, glycosylation was abolished, confirming that the residues are extracellular
NGEP is a potential target for T cell-mediated immunotherapy of prostate cancer.
This prostate-specific gene encodes a cytoplasmic protein, as well as a polytopic membrane protein which may serve as a target in prostate cancer diagnosis and immunotherapy. Alternative splicing results in multiple transcript variants encoding different isoforms.
, Dresden-transmembrane protein of the prostate
, prostate cancer associated protein 5
, transmembrane protein 16G
, transmembrane protein 16g